Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: SP Appreciation into April Quarterly

I am thinking PTSC will report ~ 30 million to 50 million with all licenses.

In my opinion this is light. Are you stating our half?

I guess 50-60 million our share of the J's alone. Plus the others.

Share
New Message
Please login to post a reply